Daily BriefsMost Read

Most Read: Tokyo Stock Exchange Tokyo Price Index Topix, S.M.Entertainment Co, Bellevue Gold, Rakuten, Indus Towers, Rakuten Bank, Sumitomo Mitsui Financial Group, Osstem Implant, ASICS Corp and more

In today’s briefing:

  • The BIG March 2023 “Wednesday Thursday Trade”
  • S.M. Entertainment: Proration Musings
  • S&P/​​​​​​ASX Index Rebalance Preview: Changes from Now to June
  • Rakuten Bank (5838 JP) IPO: Listing in April, TPX Inclusion in May, MSCI SC in August
  • India: AMFI Stock Reclassification Preview (June 2023)
  • Rakuten Bank (5838 JP) – Another Net-Bank IPO, This One With TOPIX and Other Index Inclusions
  • Japan Banks: Markets Overreact to SVB’s Collapse
  • MBK/Unison Launch ANOTHER Tender on Osstem Implant (048260 KS) To Squeeze Out Minorities
  • MBK/Unison Capital Announces a Second Tender Offer for Osstem Implant to Take It Private
  • ASICS (7936) | Running Is Recession Proof

The BIG March 2023 “Wednesday Thursday Trade”

By Travis Lundy

  • Every year it’s the same trade. But it isn’t really. But it kinda is. This year it is Wednesday and Thursday. There are risks to the analysis – notably allocation.
  • But, ceteris paribus, it is still possibly a ¥1,580,876,450,407 buying spree to take place on one day into the close later this month. Or something close to it.
  • And for a two-day period, over the last ten years, the average return is 1.60% on these two days with a 9:1 win ratio. Lots of angles here.

S.M. Entertainment: Proration Musings

By David Blennerhassett

  • After HYBE (352820 KS) conceded to Kakao Corp (035720 KS) earlier this month, S.M.Entertainment Co (041510 KS)‘s shares have declined 23%. 
  • Kakao’s Partial Offer of  ₩150,000/share closes on the 26 March. 
  • Unadjusted proration is 36.8%, conservatively rising to 48.5%. It may settle at 61% if HYBE maintains its position – but that is probably a tad optimistic. 

S&P/​​​​​​ASX Index Rebalance Preview: Changes from Now to June

By Brian Freitas


Rakuten Bank (5838 JP) IPO: Listing in April, TPX Inclusion in May, MSCI SC in August

By Brian Freitas

  • Rakuten Bank (EBANKZ JP)‘s listing has been approved by the JPX and the stock is expected to start trading on the Prime Market from 21 April.
  • News reports indicate a raise of US$800mn (JPY 106.8bn) at the mid-point of the IPO range, valuing the company at JPY 305bn (US$2.3bn). 
  • The stock should be added to the TPX INDEX at the close on 30 May where trackers will need to buy over 14% of the stock issued in the IPO.

India: AMFI Stock Reclassification Preview (June 2023)

By Brian Freitas

  • Nearly halfway through the review period, we see 10 stocks moving from MidCap to LargeCap and vice versa, and 9 stocks moving from SmallCap to MidCap and vice versa.
  • Financials are poised to be the biggest gainers in the reshuffle with 6 stocks moving from MidCap to LargeCap and 5 stocks moving from SmallCap to MidCap.
  • Over the last 6 months, stocks expected to migrate upward have outperformed stocks that are expected to migrate downward., though there has been a downward drift this year.

Rakuten Bank (5838 JP) – Another Net-Bank IPO, This One With TOPIX and Other Index Inclusions

By Travis Lundy


Japan Banks: Markets Overreact to SVB’s Collapse

By Oshadhi Kumarasiri

  • Following the collapse of SVB and Signature Bank last week, Japan’s big four banks have fallen by around 15% due to their exposure to US government bonds.
  • However, the Japanese banks have managed the interest rate risk far better than the collapsed US banks and therefore, we feel the price drop is unwarranted.
  • With Japan likely to scrap its zero rates policy, we think this could be a rather intriguing opportunity to make generous gains on the long side in Japan’s banking sector.

MBK/Unison Launch ANOTHER Tender on Osstem Implant (048260 KS) To Squeeze Out Minorities

By Travis Lundy


MBK/Unison Capital Announces a Second Tender Offer for Osstem Implant to Take It Private

By Douglas Kim

  • MBK/Unison Capital consortium announced a second tender offer for Osstem Implant (048260 KS) today in order to take the company private. 
  • The tender offer price is 190,000 won per share, which is the same price as the first tender offer price.
  • The number of shares for the tender offer is 1,654,916, accounting for 10.62% of the outstanding shares.

ASICS (7936) | Running Is Recession Proof

By Mark Chadwick

  • Good news from Nike’s Q3 report, which bodes well for Asics March quarter
  • Why was Nike’s stock down? Margins were down 330bps on inventory mark downs
  • Running is recession proof according to the footwear makers themselves

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars